Abstract The visinin-like protein (VSNL) subfamily, including VILIP-1 (the founder protein), VILIP-2, VILIP-
importance of the regulative function of Ca 2+ in neurons. The founding members were visinin and recoverin, expressed in the retina of various species (Yamagata et al. 1990; Dizhoor et al. 1991) . By the end of the 1990s, these proteins had been grouped together and termed neuronal Ca 2+ sensor (NCS) proteins (Nef 1996; Braunewell and Gundelfinger 1999) . Fourteen NCS protein genes are known to exist to date in various species and have been subdivided into five subfamilies. Previous reviews have nicely given an overview on the whole family of NCS proteins Burgoyne and Weiss 2001; Burgoyne 2007) . To give a more-detailed description of current knowledge, we have focused here mainly on the subfamily of visinin-like proteins (VSNLs).
Five proteins, VILIP-1 (visinin-like protein 1, gene name VSNL1), VILIP-2 (visinin-like protein 2, gene name hippocalcin-like 4, HPCAL4), VILIP-3 (visinin-like protein 3, VILIP-3, gene name HPCAL1), hippocalcin (gene name HPCA), and neurocalcin δ (gene name: NCALD), show a high degree of amino acid identity of 67% to 94% (Fig. 1a, b) and form the subfamily of VSNLs Burgoyne and Weiss 2001; Spilker et al. 2002a; Burgoyne et al. 2004 ). The founder member of the subfamily, VILIP-1, was initially cloned as neural visinin-like protein 1 (NVP-1) from rat (Kuno et al. 1992) and visinin-like protein from chicken (Lenz et al. 1992) . A variety of different names have been given to these proteins in different species over time (Fig. 1a) , which often makes it difficult to obtain a comprehensive picture for a given protein in the literature. Thus, it might be most beneficial for the scientific community to add the official gene names and thereby comply with the recommendation of the HUGO Gene Nomenclature Committee (http://www.genenames. org). An overview of the nomenclature with the official gene names is also provided in Fig. 1a . Within the VSNL subfamily, two branches show 67%-69% homology (Fig. 1a) . Branch 1 with VILIP-1 and VILIP-2 are 89% homologous, whereas branch 2 with hippocalcin and VILIP-3 share 94% identity, hippocalcin and VILIP-3 being 91% identical to neurocalcin δ (Spilker et al. 2002a ). VSNLs are 191-193 amino acid residues long and have a consensus sequence (M-G-(X) 3 -S) for N-terminal myristoylation (Fig. 1b) . Like all other members of the superfamily of EF-hand Ca 2+ -binding proteins, VSNLs possess the sequence motif D-X-D/N-X-D/N-X-Y-(X) 4 -E as the EFhand Ca 2+ binding motif, where amino acids in bold are involved in the coordinative binding of Ca
2+
, and where X can be any amino acid (Fig. 1b, EF1-EF4 ). Besides the EFhand Ca 2+ -binding motifs, no other functional domains have been identified as yet. Because of changes in this amino acid sequence, e.g., the removal of Asp and Asn involved in coordinative binding and the addition of positively charged residues, EF-hand 1 (EF1) is dysfunctional in all VSNLs.
EF1 also forms the most variable part in the sequence of NCS proteins and therefore comprises a possible interaction site with target proteins.
Distribution of VSNLs in the central nervous system
The expression patterns of NCS proteins and mRNAs have been previously reviewed indicating that VSNLs show a widespread but distinct expression pattern primarily in nerve cells . A detailed mRNA expression study of the VSNL subfamily describes the expression of VILIP-1, VILIP-2, VILIP-3, and hippocalcin in the rat brain (Paterlini et al. 2000) . VILIP-1 mRNA shows a widespread distribution in most brain areas, except the caudate-putamen. Hippocalcin and VILIP-3 exhibit overlapping expression patterns in the forebrain including the neocortex, hippocampus, and caudate-putamen. VILIP-3 seems to have a restricted expression pattern in the cerebellum, where it localizes to Purkinje and granule cells (Paterlini et al. 2000) . A novel and powerful tool for studying and comparing the expression of the mRNAs for VSNLs, e.g with potential interaction partners, in the mouse brain and spinal cord is the Allen Brain Atlas (http:/www.brain-map.org).
At the protein level, several comparative expression studies for members of the VSNL subfamily have been performed. These studies include the analysis of protein expression of VILIP-1 and VILIP-3 in the rat cerebellum and hippocampus (Spilker et al. 2000) , of neurocalcin isoforms α and δ in the rat cerebellum (Kato et al. 1998) , and of VILIP-1 and VILIP-3 in the human brain (Saitoh et al. 1995) . Detailed studies of the distribution of VSNLs in the brain have focused on the hippocampus and cerebellum. Early studies in the hippocampus of rat and gerbil (Saitoh et al. 1995; Lenz et al. 1996a Lenz et al. , 1996b Lenz et al. , 1996c indicated that the highly homologous VILIP-1 and VILIP-2 (Fig. 1b) are differentially distributed. VILIP-2 expression is most prominent in rat CA1/CA2 regions and the dentate gyrus, whereas VILIP-1 immunoreactivity is strongest in the CA3 region in gerbil. However, in rat hippocampus, VILIP-1 shows expression in all hippocampal subregions and the dentate gyrus , which again differs from the expression profile observed in human hippocampus, where VILIP-1-immunoreactive neurons have been found to be strongly expressed in CA1, CA4, and hilus, with only weak expression in the CA2 and CA3 subfields (Bernstein et al. 1999) . Thus, in addition to regional differences of VSNL expression, species differences have to be taken into account. Hippocalcin is expressed in various parts of the rat hippocampus and is also detected in brain regions such as the cerebellum (Saitoh et al. 1994; Grant et al. 1996) . Hippocalcin mRNA and immunoreactivity are strongly expressed in the pyramidal cells of the hippocampus, intensely in cerebellar Purkinje cells, but only moderately in the dentate granule cells and pyramidal cells of cerebral cortex layers II-VI and weakly in the large neuronal cells of the caudate-putamen . VILIP-3 expression, which is highly homologous to hippocalcin, has been predominantly localized in the cerebellum, but there is also weak expression in other brain regions including the hippocampus (Spilker et al. 2000; Spilker and Braunewell 2003) . At the mRNA level, strong regional differences in the expression levels of hippocalcin and VILIP-3 are detected in rat hippocampus. Compared with other hippocampal subregions in which hippocalcin clearly dominates, a relatively high expression level of VILIP-3 and a relatively low expression level of hippocalcin are detectable in the dentate gyrus (Spilker et al. 2000) . VILIP-1 and VILIP-3 co-localize in hippocampal neurons, showing a strong expression for VILIP-1 in many neurons and weaker expression of VILIP-3 in a subset of neurons (Spilker and Braunewell 2003) . Coimmunolocalization studies of neurocalcin in the rat hippocampus have suggested that all neurocalcin-immunoreactive neurons are gamma-aminobutyric acid (GABA)-ergic. Neurocalcin-positive neurons comprise about 19% of the GABAergic neurons. These data suggest that neurocalcin is a marker for a subpopulation of interneurons. However, it has to be taken into account that the neurocalcin antibody used in the study reacted with neurocalcins α, β, γ, and δ, which are equivalent to VILIP-1, VILIP-2, VILIP-3, and neurocalcin δ (Martinez-Guijarro et al. 1998) . Recent studies with VILIP-1-specific antibodies show expression in principal and nonprincipal neurons, with very strong expression levels in a Fig. 1 subpopulation of calbindin-D28K-and calretinin-positive interneurons in various hippocampal regions .
The cerebellum is the second brain structure that has been studied in detail. Northern blots reveal that VILIP-2 is not expressed, whereas VILIP-3 is prominently expressed in the rat cerebellum (Kajimoto et al. 1993) . Immunohistochemical and in situ-hybridization data indicate that, at the cellular level, VILIP-3 is mainly expressed in Purkinje cells, with weak VILIP-3 immunoreactivity in granule cells (Spilker et al. 2000; Hamashima et al. 2001) . VILIP-1 transcripts are primarily found in the granule cell layer but are virtually absent from Purkinje cells in chicken and rat cerebellum (Lenz et al. 1992; Kato et al. 1998; Spilker et al. 2000) . Chicken and rat VILIP-1 protein and its bovine ortholog neurocalcin α are consistently absent from Purkinje cells. Immunoreactivity has been found to be restricted to granule cells and to the molecular layer of the chicken and rat cerebellum (Lenz et al. 1996a (Lenz et al. , 1996b (Lenz et al. , 1996c Kato et al. 1998; Spilker et al. 2000) . In the human, brain studies with antibodies against VILIP-1 and VILIP-3 have been performed, with expression for both proteins having been found in subsets of neurons in virtually all brain regions. However, VILIP-1 displays a much more intense immunoreactivity than VILIP-3 (Bernstein et al. 1999) . VSNLs are also expressed in neurons of sensory pathways, including the retina and olfactory system. In the retina of various species, VILIP-1 and neurocalcin δ are absent from photoreceptor cells but are expressed in subsets of bipolar, amacrine, and retinal ganglion cells (Lenz et al. 1992; Nakano et al. 1992; DeRaad et al. 1995; Krishnan et al. 2004) . Various studies have shown that, in rat olfactory epithelium, a subset of olfactory receptor neurons express VILIP-1 (Boekhoff et al. 1997; Bastianelli et al. 1995; Braunewell and Gundelfinger 1999) , hippocalcin (Mammen et al. 2004) , and neurocalcin δ (Duda et al. 2001 .
Distribution of VSNLs in the periphery
NCS proteins have been assumed to be a nervous-systemspecific gene family; however, expression outside the nervous system is receiving increasing attention. VILIP-3, which is also called REM-1, has been detected in cells of the hematopoietic system and in the gut (Kraut et al. 1995) and also in the kidney, spleen, and testis (Spilker et al. 2000) . Substantial expression of VILIP-1 has been shown for heart, liver, lung, and testis in human and rat and also in the stomach and skin of rat (Gierke et al. 2004) . VILIP-1 mRNA expression has been detected in Northern blots of heart and lung (Kajimoto et al. 1993) and by reverse transcription with the polymerase chain reaction in heart and colon (Ohya and Horowitz 2002) , and its presence in skin has been shown at the protein and mRNA levels (Mahloogi et al. 2003) . In contrast, hippocalcin displays a restricted expression pattern exclusively in brain tissues. No protein expression of hippocalcin has been detected in the periphery, although expressed sequence tag (EST) sequences have been found in a few additional peripheral tissues (Gierke et al. 2004 ). The peripheral distribution of VSNLs in relation to brain expression is much higher in embryonic tissue compared with adult rat tissues, indicating a developmental restriction of expression. A developmental decrease of VSNL expression in liver, lung, kidney, spleen, pancreas, and colon occurs, which hints at a specific function of VSNLs during organ development (Gierke et al. 2004 ). Thus, hippocalcin may have adapted to specific brain functions particularly in the hippocampus, whereas VILIP-1, neurocalcin δ, and particularly VILIP-3 fulfil specific functions in peripheral organs. In addition, EST clones containing VSNL sequences have been found in cancer tissue such as nervous tumor, hepatocellular carcinoma, adenocarcinoma, oligodendroglioma, lung squamous cell carcinoma (SCC), and head/neck tumors. Thus, VSNLs might also be involved in the pathophysiology of cancer. Indeed, the expression of VILIP-1 is lost in mouse SCC of the skin (Mahloogi et al. 2003; Gonzalez-Guerrico et al. 2005) , in human SCC of the esophagus (Wickborn et al. 2006) , and in non-small cell lung carcinomas (Fu et al. 2008) . VILIP-1 plays a role as an invasion-suppressor gene negatively influencing the invasiveness of SCC (Mahloogi et al. 2003; Gonzalez-Guerrico et al. 2005) . In contrast, VILIP-1 is overexpressed in colon cancer cell lines (Fu et al. 2008) and in neuroblastoma where it enhances neuroblastoma invasiveness (Xie et al. 2007 ). The precise signaling mechanisms leading to the opposite effects in different cell types are currently under investigation.
Ca
2+ affinities and the Ca 2+ -myristoyl switch of VSNLs
VSNLs possess a functional M-G-X 3 -S consensus sequence for N-terminal myristoylation and are able to translocate to subcellular membrane compartments by a molecular mechanism termed the Ca 2+ -myristoyl switch, which is dependent on Ca 2+ -binding and the myristoyl modification of the proteins (Zozulya and Stryer 1992) . The molecular mechanism of the switch has been analyzed in detail from tertiary structure data for recoverin, a founding member of the NCS protein family, which was analyzed in its Ca 2+ -bound and Ca 2+ -free myristoylated forms (Ames et al. 1996 (Ames et al. , 1997 . Without Ca 2+ , the four EF-hand motifs in recoverin are arranged in a compact tandem array, with the myristoyl side-chain buried in a hydrophobic pocket (Tanaka et al. 1995) . The binding of Ca 2+ to recoverin induces a conformational change leading to surface exposure of hydrophobic protein regions and exposure of the myristoyl side-chain, thereby making these structures available for interaction with cellular membranes and/or target proteins. Biochemically, the existence of the Ca 2+ -myristoyl switch mechanism has been shown for all members of the VSNL subfamily Ladant 1995; Lenz et al. 1996a Lenz et al. , 1996b Lenz et al. , 1996c Spilker et al. 2002b ). Accordingly, after increasing the intracellular Ca 2+ concentration, VSNLs can translocate to subcellular membrane compartments in living cells Spilker et al. 2002b; O'Callaghan et al. 2002 O'Callaghan et al. , 2003a Spilker and Braunewell 2003) . The Ca 2+ affinities of some VSNLs have been determined and are in the range of 200 nM to 10 μM (Cox et al. 1994; Ladant 1995 , O'Callaghan et al. 2005 Jheng et al. 2006 ). Unmyristoylated VILIP-1 was initially shown to have uncooperative Ca 2+ binding with an affinity of 1 μM (Cox et al. 1994) . Unmyristoylated neurocalcin δ showed cooperative binding with an affinity of 0.6 μM (Ladant 1995) . When unmyristoylated VILIP-1/neurocalcin α and neurocalcin δ were compared, they showed half-maximum changes in tryptophan fluorescence signals at 1.5 and 6.1 μM free-Ca 2+ , respectively (Kato et al. 1998) . Another recent comparison of unmyristoylated VILIP-1 and VILIP-3 has revealed slightly higher and cooperative Ca 2+ affinities of 5.8 μM for VILIP-1 and 13.9 μM for VILIP-3 (Jheng et al. 2006) . The reason for these lower Ca 2+ affinities is currently unclear but might be partially related to the use of intact Hisand GST-fusion proteins compared with recombinant proteins with a cleaved-off fusion part. Large GST fusion proteins might influence affinities adversely. In living HeLa cells, the Ca 2+ -concentration range necessary for the Ca 2+ -myristoyl switch and membrane association of myristoylated hippocalcin has been evaluated to be in the range of 200-800 nM free-Ca 2+ (O'Callaghan et al. 2003a ). Thus, the precise Ca 2+ affinities for VSNLs still have to be determined, but comparative studies of myristoylated native proteins in living cells will most likely reflect more precisely their physiological calcium affinities, which are known to be strongly influenced by myristoylation (Ladant 1995) .
Possible impact of the Ca 2+ myristoyl switch of VSNLs
The reversible localization of signaling proteins and of Ca 2+ sensors to distinct membrane compartments and signaling scaffolds in living neurons via the molecular mechanism of the Ca 2+ -myristoyl switch has been postulated to be a signal transduction mechanism for the selective activation of downstream signaling cascades, such as receptors, receptor signaling complexes, and signal effector molecules (Teruel and Meyer 2000; Spilker et al. 2002b; Spilker and Braunewell 2003) . VSNLs have been shown to translocate from the cytosolic to the particulate fraction in a Ca 2+ -dependent manner in biochemical fractionation experiments Ladant 1995; Lenz et al. 1996a Lenz et al. , 1996b Lenz et al. , 1996c Kato et al. 1998; Spilker et al. 2000) , and when co-expressed in neural cell lines, VSNLs exhibit similar Ca 2+ -myristoyl switch properties in living cells Spilker et al. 2002b; O'Callaghan et al. 2002 O'Callaghan et al. , 2003a . However, differences in the degree and/or mechanism of Ca 2+ -dependent membrane association became evident in biochemical experiments with VILIP-1 and VILIP-3 following repeated EGTA extraction of the membrane fraction. Under these conditions, VILIP-1 is less extractable from the membrane fraction compared with VILIP-3 (Spilker et al. 2002a ). Moreover, neurocalcin α and δ, the bovine counterparts of VSNLs, have different Ca 2+ affinities, and the degree of the Ca 2+ -induced conformational change differs as shown by Ca 2+ overlay, gel migration assay, and tryptophan fluorescence assay (Kato et al. 1998) . VILIP-1 and VILIP-3 appear to differ in their Ca 2+ affinities (Jheng et al. 2006) . In agreement with these biochemical data, the membrane association of VILIP-1 and VILIP-3 also appears to vary. VILIP-1 displays tight membrane association in granule cells, whereas VILIP-3 is evenly distributed in Purkinje cells (Spilker et al. 2002a ). An equivalent subcellular distribution has been observed in hippocampal neurons co-expressing VILIP-1 and VILIP-3; this strongly indicates that these differences reflect the intrinsic properties of the proteins (Spilker and Braunewell 2003) . The Ca 2+ -dependent subcellular membrane localization of endogenously expressed VILIP-1 and VILIP-3 differs substantially in the same hippocampal neuron. VILIP-1 shows association with the cell-surface membrane, including membranes of axons and dendrites, which is in accord with the described function of VILIP-1 as a modulator of cell-surface-associated proteins (Braunewell et al. , 2001a Lin et al. 2002a Lin et al. , 2002b . In addition, VILIP-1 only affiliates with trans-Golgi membranes following a Ca 2+ stimulus in hippocampal neurons (Spilker and Braunewell 2003) , whereas VILIP-3 shows a weak Ca 2+ -independent Golgi localization that is only gradually enhanced following stimulation of hippocampal neurons (Spilker et al. 2002b ). Furthermore, VILIP-3 interacts with intracellular juxtanuclear membranes and granular structures in the whole cytosol (Spilker and Braunewell 2003) , in agreement with a possible function as a modulator of mitogen-activated protein (MAP) kinases (Spilker et al. 2002a) . Interestingly in this context, an enhanced juxtanuclear localization of VSNLs exists under conditions of disturbed Ca 2+ homeostasis in Alzheimer's disease (AD; Braunewell et al. 2001b; Blandini et al. 2004 ). In the case of VILIP-1 and VILIP-3, the observed in vitro differences in Ca 2+ affinities have been found to be paralleled by differences in subcellular localization and activity-dependent translocation to cellular signaling compartments, when VILIP-1 and VILIP-3 are co-expressed ( Fig. 2 ; Kato et al. 1998; Spilker et al. 2002a Spilker et al. , 2002b . Thus, each NCS protein might respond to different Ca 2+ concentrations and, thus, might have specificity for certain celltypes and specificity toward distinct receptors and signaling pathways (Burgoyne 2007) . The in vitro differences in Ca 2+ affinities for NCS proteins might increase the dynamic range over which Ca 2+ and NCS proteins can regulate neuronal activities (Burgoyne and Weiss 2001; Burgoyne 2007) . Further comparative analysis of the functions of VSNLs will be crucial to an understanding of the precise functional impact of the switch. 
Effect of VSNLs on signal transduction cascades

VILIP-1 affects cAMP signaling
Initially, the regulation of cAMP levels by VILIP-1 was detected in stably transfected rat C6 glioma cells . The myristoylation-deficient mutant of VILIP-1, which lacks the myristoylation consensus motif and therefore does not exhibit the Ca 2+ -myristoyl switch, showed a dominantnegative effect on cAMP levels in C6 cells. Low cAMP levels appeared to be elevated in VILIP-1-transfected C6 cells, thereby causing the induction of differentiation in these glioma cells . Since the effect of VILIP-1 on adenylyl cyclase was not observed in other neural cell lines tested, such as PC12 or Neuro2A cells, the results pointed to an isoform-specific effect of VILIP-1 . Further support from more recent results indicates that VILIP-1 influences adenylyl cyclase activity in selected cell types including human embryonic kidney cells (Lin et al. 2002b) , the pancreatic β cell line MIN6 (Dai et al. 2006) , and various skin tumor cell lines (Mahloogi et al. 2003) . High-level expression of VILIP-1 occurs in less aggressive SCC lines, but the expression is lost in more aggressive tumor cells. The reduced expression correlates with decreased cAMP levels, which in turn lead to increased expression of the metalloproteinase MMP-9 and enhanced rhoA activity. The loss of VILIP-1 and its effect on cAMP-dependent signaling accelerates the invasiveness of carcinoma cells; this can be reversed by forcing the expression of VILIP-1 and, thus, increas- ing VILIP-1-induced cAMP levels (Mahloogi et al. 2003) . Moreover, VILIP-1 is expressed in murine pancreatic islets and β cells. Overexpression of VILIP-1 in the MIN6 β cell line or isolated mouse islets increases cAMP levels and, at the same time, increases glucose-stimulated insulin secretion, whereas knock-down of VILIP-1 decreases cAMP levels significantly. Similarly, the protein kinase A inhibitor H-89 attenuates increased glucosestimulated insulin secretion. Thus, the effect of VILIP-1 on adenylyl cyclase in β cells is accompanied by enhanced exocytosis (Dai et al. 2006) . Finally, VILIP-1 directly inhibits olfactory adenylyl cyclase type III activity in a Ca 2+ -dependent manner in olfactory membrane assays following odor stimulation, although at fairly high micromolar protein concentrations. These findings agree with the strong VILIP-1 immunoreactivity found in the olfactory epithelium, especially in the olfactory knobs enriched in olfactory signaling cascades . Although the effect of VILIP-1 on olfactory guanylyl cyclase has not as yet been tested, the protein has been discussed as an additional modulator of olfactory adaptation processes (Boekhoff et al. 1997 ). Thus, the data obtained in highly different cellular systems suggest a modulatory role for VILIP-1 on the activity of distinct adenylyl cyclase isoforms. No direct interaction of VILIP-1 with adenylyl cyclase isoforms has been detected, and thus, indirect modulation, for instance by regulating the trafficking and surface expression of distinct adenylyl cyclase isoforms, might be possible. In peripheral organs, the VILIP-1 effect on cAMP signaling appears to have important pathophysiological implications and identifies the protein as a putative tumor metastasissuppressor gene for human SCC and non-small cell lung carcinoma (Wickborn et al. 2006; Fu et al. 2008 ).
VILIP-1 affects cGMP signaling
In stably transfected neural cell lines including C6 glioma, PC12 pheochromocytoma, and Neuro2A neuroblastoma cells, VILIP-1 affects cGMP levels. Following the stimulation of receptor GCs with natriuretic peptides, an enhanced cGMP accumulation was observed in the three cell lines stably expressing VILIP-1. The effect of VILIP-1 on the particulate receptor cyclases GC-A (NPR-A) and GC-B (NPR-B) depends on myristoylation and membranelocalization of wild-type VILIP-1 and is strongly reduced with a myristoylation mutant (Braunewell et al. 2001a (Braunewell et al. , 2001b . Thus, VILIP-1 influences not only adenylyl cyclases, but also non-retinal receptor guanylyl cyclases, namely the receptor GC-A and GC-B in vitro. Moreover, the effect of VILIP-1 on cGMP signaling has also been found in primary cerebellar cultures, where the protein specifically affects neuronal GC-B, but not GC-A, which is expressed in glial cells. The relevance of the effect of VILIP-1 on GC-B activity has further been investigated in primary hippocampal neurons in which heterologous VILIP-1-expression leads to an increase in the surface expression of GC-B and thereby enhances basal and CNPstimulated cGMP accumulation. VILIP-1 attenuates the internalization of GC-B either by affecting endocytosis or recycling of the receptor. Thus, VILIP-1 might influence cGMP-dependent neuronal processes, including neuronal differentiation, neurite outgrowth, various forms of synaptic plasticity, and learning and memory (Schuman and Madison 1991; Telegdy 1994; Monfort et al. 2002) . VILIP-1 also interferes with the recycling of the unrelated transferrin receptor and with clathrin-distribution in cells, indicating that the calcium sensor might be a general modulator of membrane trafficking (Brackmann et al. 2005 ).
VILIP-1 modulates α 4 β 2 nicotinic acetylcholine receptors VILIP-1 interacts with α 4 β 2 nicotinic acetylcholine receptors (nAChR) and is able to modulate nAChR function (Lin et al. 2002a; Gierke et al. 2008 ). Co-expression of VILIP-1 with recombinant α 4 β 2 nAChR up-regulates the surface expression levels by two-fold and increases the agonist sensitivity to acetylcholine by three-fold. The VILIP-1 myristoylation mutant or mutants not able to bind Ca 2+ are found to attenuate the modulation of α 4 β 2 nAChR (Lin et al. 2002a ). In hippocampal neurons, VILIP-1 has been shown to enhance surface expression and ligand sensitivity by affecting membrane trafficking of the receptor. VILIP-1 and α 4 β 2 nAChR occur in a complex with the trans-Golgi SNARE syntaxin 6, involved in Golgi to surface membrane trafficking and constitutive exocytosis. Furthermore, VILIP-1 and α 4 β 2 nAChR are co-localized in a subpopulation of interneurons in the hippocampus . Enhanced expression of VILIP-1 in interneurons in hippocampal cultures leads to an enhancement of acetylcholine-evoked IPSCs (inhibitory postsynaptic currents) of nearby pyramidal neurons (Gierke et al. 2008 ). These results suggest that VILIP-1 represents a novel modulator of α 4 β 2 nAChR and increases the surface expression level and agonist sensitivity of the receptor in response to changes in the intracellular levels of Ca 2+ . Through the co-localization of VILIP-1 with α 4 β 2 nAChR, particularly in interneurons, an enhancement of GABAergic neurotransmission is achieved, leading to increased IPSC activity in pyramidal neurons, thereby changing the activity of the whole hippocampal network (Gierke et al. 2008 ).
VILIP-2 modulates P/Q-type Ca 2+ channels Branch 1 of the VSNLs also includes VILIP-2, which is 89% homologous to VILIP-1. Little functional data are available for VILIP-2, which seems to bind to the presynaptic P/Q-type Ca 2+ channel (CaV2.1). During the co-expression of VSNL-2 with CaV2.1, an effect on the CaV2.1 inactivation rate was observed, which differed from the effect of calmodulin and CaBP1, and which was dependent on N-terminal myristoylation Lautermilch et al. 2005) . Ca 2+ -activated calmodulin causes facilitation and enhances inactivation of CaV2.1 channels, whereas Ca 2+ -binding protein 1 (CaBP1; a neurospecific CaM-like Ca 2+ binding protein) accelerates inactivation and prevents facilitation. In contrast, myristoylated VILIP-2 does not alter CaV2.1 channel facilitation but slows the rate of inactivation and reduces the inactivation of Ca 2+ currents of the CaV2.1 channel during trains of repetitive depolarizations . These data suggest that, by regulating presynaptic CaV2.1 channels, VILIP-2 and other calcium sensors can shape presynaptic Ca 2+ transients, thereby affecting the time course and amount of neurotransmitter release. VILIP-1 might act as a potent regulator of synaptic transmission . It is not known whether VILIP-2 influences the signaling pathways affected by VILIP-1, and vice versa. However, despite their high homology the two proteins might have evolved to fulfill different cellular functions as indicated by their differential distribution in the cerebellum, where VILIP-1 but not VILIP-2 is present (Kajimoto et al. 1993) , and the hippocampus where they show a differential distribution pattern (Saitoh et al. 1995) .
Neurocalcin δ affects receptor guanylyl cyclases
The second branch of VSNLs comprise hippocalcin, VILIP-3, and neurocalcin δ with homologies between 91% and 94%. Similar to VILIP-1 and VILIP-2, they show differential expression patterns, e.g., with hippocalcin showing high abundance in the hippocampus and VILIP-3 being prevalent in the cerebellum. VILIP-3 is the least-well examined compared with hippocalcin and neurocalcin δ and with respect to its function. Neurocalcin δ, like VILIP-1 and hippocalcin, influences cGMP signaling by acting as a Ca 2+ -dependent regulator of the retinal guanylyl cyclase retGC1 (GC-E; Kumar et al. 1999; Duda et al. 2001 Duda et al. , 2004 Krishnan et al. 2004 ). RetGC1 and neurocalcin δ co-localize in neurons in the inner plexiform layer of the retina, e.g., in amacrine and ganglion cells, where they might influence synaptic signaling processes ). This effect is specific for retGC1, since no influence on retGC2 or GC-A has been observed (Kumar et al. 1999) , the latter being a target for VILIP-1 (Braunewell et al. 2001a (Braunewell et al. , 2001b . Neurocalcin δ interacts with retGC1 and influences its function at a Ca 2+ concentration of 1 µM. The halfmaximal activity of neurocalcin δ was calculated to be 0.8 µM. Neurocalcin δ is expressed in the olfactory epithelium and can interact and activate the olfactory guanylyl cyclase (GC-D) with similar sensitivity . Ca 2+ -bound myristoylated Neurocalcin δ binds to the catalytic domain of the olfactory GC-D and stimulates the cyclase with a half-maximal activity of approximately 0.8 µM neurocalcin δ . Thus, neurocalcin δ is the second member of the VSNL subfamily to influence guanylyl cyclase family members.
Hippocalcin and adenylyl and guanylyl cyclase signaling Hippocalcin, similar to VILIP-1 and neurocalcin δ, is the third VSNL to influence cyclic nucleotide signaling. At high Ca 2+ concentrations, the activation of the olfactory adenylyl cyclase, but inhibition of the olfactory guanylyl cyclase ONE-GC (GC-D), has been observed in membrane assays (Mammen et al. 2004 ). This effect is the opposite to that found for VILIP-1, which inhibits olfactory adenylyl cyclase (Boekhoff et al. 1997 ) but activates the natriuretic peptide receptor GC-B, which is abundantly expressed in the brain including the hippocampus and the olfactory epithelium (Braunewell et al. 2001a (Braunewell et al. , 2001b Brackmann et al. 2005) . Thus, VILIP-1, neurocalcin δ, and hippocalcin might be involved in the fine-tuning of stimulus detection and odor adaptation mediated by cyclic nucleotide signaling in the olfactory epithelium. Moreover, a GST fusion protein pulldown approach coupled with MALDI-MS and Western blotting has shown that hippocalcin and neurocalcin δ interact with CaM-dependent cyclic nucleotide 3′,5′-phosphodiesterase (PDE) and CAPS1, a Ca 2+ -dependent activator protein for secretion, which is involved in dense-core vesicle exocytosis . Influence of the cAMP-PDE would provide yet another opportunity to influence cyclic nucleotide signaling, in addition to influencing cyclases directly. However, the functional consequences of these interactions have not as yet been determined.
Hippocalcin and ERK signaling
Several lines of evidence indicate that hippocalcin influences the MAPK and related pathways. In a yeast two-hybrid interaction screen, hippocalcin was identified as a possible interaction partner of MLK2/3 (mixed-lineage Ser/Thr kinases; Nagata et al. 1998) . MLKs are closely related to the MAP kinase kinase kinase (MAPKKK) family (Tibbles and Woodgett 1999) . MLK2 and 3 interact with the small GTPases Rac and Cdc42 and with motor proteins of the kinesin superfamily and co-localize with the tubulin cytoskeleton, suggesting that they are involved in the regulation of cellular cytoskeleton dynamics. MLK2/3 activates JNK (c-Jun N-terminal kinase), ERK (extracellular signal-regulated kinase), and p38 (Tibbles and Woodgett 1999) . However, to date, no influence on the kinase activity of MLKs has been observed. Therefore, the biological significance of the MLK-hippocalcin interaction remains unclear. In transgenic hippocalcin -/-mice, an impaired cAMP-response element-binding protein (CREB) activation was observed, possibly caused by a malfunctioning ERK cascade, since an ERK cascade inhibitor blocked N-methyl-D-aspartate (NMDA)-and KCl-stimulated CREB phosphorylation in control hippocampal slices but not in the knock-out mice . When the Ca 2+ -dependent Ras/Raf/MEK/ERK signaling cascade was further tested, no direct effect of Ca 2+ -bound hippocalcin on Raf-1 kinase or MEK was observed. Hippocalcin also had no effect on the activation of ras; however, the hippocalcin -/-mice still displayed a defect in the NMDA-and KCl-induced activation of Raf-1 kinase and ERK activation. This is explained as a possible effect of hippocalcin on alternative Raf-1 kinase activation pathways, such as protein kinase B/Akt and 14-3-3 protein (Noguchi et al. 2007 ). Noteworthy, hippocalcin in conjunction with the small rho-like GTPase cdc42 leads to a 1.8-fold increase in Ca 2+ -dependent, but protein-kinase-C-independent phospholipase D (PLD) activation. Hippocalcin alone does not activate PLD. This has been postulated to be related to MAPK-dependent activation of PLD (Hyun et al. 2000) . One testable possibility would be that hippocalcin affects MAPK signaling via regulating gene expression.
Similar effect of VILIP-3 and hippocalcin on ERK signaling and microsomal monooxygenase VILIP-3 is mainly expressed in cerebellar Purkinje cells and might therefore be specialized to fulfil the signaling requirements of this neuronal cell type (Spilker et al. 2000 (Spilker et al. , 2002a . However, its expression in hippocampal neurons (Spilker and Braunewell 2003) and in many peripheral organs (Pribanic et al. 2003; Gierke et al. 2004 ) also indicates more general functions. VILIP-3 in contrast to VILIP-1, does not influence cGMP signaling (Spilker et al. 2002a) . Differences in the membrane-association properties of VILIP-1 and VILIP-3 (Spilker and Braunewell 2003) , together with the finding that both proteins interact with a different set of putative binding partners (Spilker et al. 2002a) , make it likely that VILIP-3 activates a distinct set of signaling cascades. Since VILIP-3 is highly homologous to hippocalcin, and since hippocalcin was found initially to interact with MAP kinases (Nagata et al. 1998) and later on was shown to influence the phosphorylation of the MAPkinase ERK2 , an effect of VILIP-3 on MAPK activation seems likely. Theoretically, as reduced ERK2-activation has been demonstrated in hippocalcindeficient mice , the overexpression of VILIP-3 should lead to increased ERK activation. This was investigated in transfected PC12 cells following VILIP-3 transfection; a difference in the degree of ERK1/ 2-phosphorylation was detected in comparison with nontransfected cells (Spilker et al. 2002a) . The finding that VILIP-3 associates with intracellular juxtanuclear membranes and granular structures in neurons (Spilker and Braunewell 2003) agrees with its possible function as a putative modulator of ERK1/2 MAP kinases. Moreover, VILIP-3 and hippocalcin have been shown to interact with the microsomal cytochrome b5, located in the endoplasmic reticulum/perinuclear region (Oikawa et al. 2004 ). The observed Ca 2+ -dependent translocation to the trans-Golgi and endoplasmic-reticulum-rich perinuclear region indicates that VILIP-3 influences the microsomal monooxygenase complex composed of Cyb5-reductase, cytochrome P450, and other reductases of the endoplasmic reticulum (Oikawa et al. 2004) . To date, the functional implications of these interactions are still unknown. Additionally, VILIP-3-expressing cells also show an effect on ERK2 protein expression, indicating that VILIP-3 affects the gene expression of these downstream signaling proteins.
Effects of VSNLs on gene expression, intracellular trafficking, synaptic plasticity, and neurodegeneration
VSNLs directly or indirectly affect gene expression
In hippocalcin -/-mice, NMDA-stimulation-and depolarization-induced phosphorylation of CREB was shown to be attenuated, suggesting an impairment in an activity-dependent gene expression cascade . Similar to these reports on hippocalcin-dependent CREB phosphorylation, hippocalcin appears to be involved in ERK-mediated transcriptional regulation of PLD2 expression (Oh et al. 2006) . Thus, hippocalcin might influence gene expression Oh et al. 2006) . Moreover, basic fibroblast growth factor (bFGF) induces hippocalcin expression in the immortalized hippocampal cell line H19-7 cells through PLC-gamma activation, which then leads to neurite outgrowth. Overexpression of hippocalcin dramatically elongates neurites and increases the expression of basic helix-loop-helix transcription factor, NeuroD. Treatment of H19-7 cells with hippocalcin short interfering RNA (siRNA) completely blocks the bFGF-induced neurite outgrowth and NeuroD expression (Oh et al. 2008 ). These results indicate that hippocalcin affects neurite outgrowth via regulating NeuroD. NeuroD has been implicated in neuronal differentiation. The precise mechanism of the hippocalcin effect on NeuroD activity is unclear yet. Similarly, overexpression of VILIP-1 in mouse pancreatic β cells increases cAMP levels and is accompanied by increased transcription of preproinsulin mRNA. VILIP-1 also influences the expression of genes involved in cell-cycle regulation, such as cyclin D2, Gsk3b, and transcription factors, such as CREB and the homeodomain transcription factor pdx-1 (Dai et al. 2006) . VILIP-1 has also been shown to bind, in a calciumdependent manner, to the double-stranded RNA of the neurotrophin receptor, trkB, localized to hippocampal dendrites (Mathisen et al. 1999) , implying that VILIP-1 also plays a role in the regulation of gene expression. Moreover, VILIP-1 was found to be upregulated in highly invasive human neuroblastoma cells, where it potentiated adhesiondependent apoptosis-resistance (anoikis-resistance) of neuroblastoma cells (Xie et al. 2007 ). Increased VILIP-1 expression leads to the upregulation of anoikis inhibitor trkB but also to the downregulation of intracellular adhesion molecule 1 (ICAM-1), major histocompatibility complex class I (MHC-1), and cell adhesion molecules CD44 and CD44v6. Thereby, VILIP-1 has been shown to regulate cell migration of neuroblastoma cells, and hence to influence the invasive properties of brain tumor cells. Taken together, these results suggest that VSNLs play a role in gene expression either indirectly via increasing cAMP levels, with ERK or rafkinase signaling acting on transcription factors such as CREB, or directly acting as modulators of transcription factors such as NeuroD. Interestingly in this context, KChIPs (potassium channel interacting proteins), a related subfamily of NCS proteins, act as Ca 2+ -dependent transcriptional repressors through direct binding to the downstream regulatory element (DRE) sequence present in a variety of genes (Carrion et al. 1999 , Link et al. 2004 ). Particularly KChIP3, also known as DREAM (DRE antagonistic modulator), has been shown to control the expression of genes such as prodynorphin, the apoptotic hrk gene, and the thyroblobulin gene (Carrion et al. 1999; Sanz et al. 2001; Cheng et al. 2002; Rivas et al. 2004; Zaidi et al. 2006 ). DREAM has also been shown to interact directly with transcription factors such as CREM and CREB (Ledo et al. 2000 (Ledo et al. , 2002 Mellström et al. 2008) . To date, it is not clear whether VSNLs also directly bind to transcription factors and thereby influence gene expression or whether the effects are mostly indirect via affecting MAPK and cAMPsignaling pathways.
Hippocalcin affects AMPAR endocytosis, potassium channels, and synaptic plasticity Increasing evidence shows that NMDA-receptor (NMDAR)-dependent activation of the MAPK pathway and the associated CREB-translational activation are critical for neuronal plasticity and represent an important molecular mechanism for learning and memory mechanisms ). In agreement with this notion, hippocalcin -/-mice display deficits in spatial and associative memory . Moreover, hippocalcin has been shown to function as a Ca 2+ sensor in hippocampal long-term depression (LTD; Palmer et al. 2005) . Hippocalcin has been implicated in the Ca 2+ -dependent endocytosis of the GluR1 subunit of glutamate receptors of the AMPA type (AMPAR) relevant for NMDAR-dependent LTD. AMPAR endocytosis leads to the depression of synaptic plasticity in the hippocampus (Palmer et al. 2005) . More recently, hippocalcin was shown to gate the, as yet unidentified, potassium channel that mediates the slow after-hyperpolarization current (IsAHP) in the hippocampus of hippocalcin -/-mice (Tzingounis et al. 2007 ). Thus, the Ca 2+ -dependent modulation of IsAHP by hippocalcin may also affect NMDAR-mediated plasticity and memory formation. These results show, once again, the usefulness of the transgenic approach for unraveling physiological functions of NCS proteins.
VSNLs as mediators of Ca 2+ -regulated neurotoxicity: neuroprotective versus neurotoxic roles For VILIP-1 and VILIP-3, the number and staining intensity of immunoreactive neurons has been reported to be reduced in the temporal cortex and in parts of the limbic system (the entorhinal cortex) in AD brains (Braunewell et al. 2001b ). These findings have pointed to an involvement of the two NCS proteins in the pathology and possibly pathophysiology of changed calcium homeostasis and hint at the high vulnerability of VILIP-1-expressing neurons in AD. In calcium-induced cytotoxicity assays in PC12 cells transfected with VILIP-1 and/or the calcium buffer protein calbindin-D28K, VILIP-1 expression enhanced the neurotoxic effect of the calcium ionophor ionomycin, whereas calbindin-D28K protected against ionomycin-induced cytotoxicity (Schnurra et al. 2001) . VILIP-1 expression also enhanced hyperphosphorylation of tau protein, compared with non-transfected cells. Again, this VILIP-1 effect was attenuated via co-expression with calbindin-D28K. Interestingly, VILIP-1 was also found to be associated with fibrillary tangles in AD brains (Braunewell et al. 2001b ). In contrast, hippocalcin was shown to be neuroprotective in various different neurotoxicity assays. Hippocalcin interacts with NAIP, the neuronal apoptosis inhibitory protein, and co-expression of both proteins synergistically facilitates neuronal survival against calcium-induced-death stimuli, such as ionomycin and thapsigargin (Mercer et al. 2000) . Whereas NAIP-hippocalcin interaction rescues neuroblastoma cells from cell death induced by high levels of calcium, no significant effect on neuronal death induced by nerve growth factor (NGF) withdrawal has been observed in sympathetic neurons (Lindholm et al. 2002) . These findings are supported by data from hippocalcin -/-mice, which are more sensitive to thapsigargin-induced cell death and excitotoxicity caused by kainic acid and quinolinic acid (Korhonen et al. 2005; Masuo et al. 2007 ). Moreover, these mice display increased caspase-12 activation and an age-dependent increase in neurodegeneration (Korhonen et al. 2005) . Thus, VSNLs might play both neurotoxic and neuroprotective roles in different types of neurons in the central and peripheral nervous systems. Further investigations into the possible involvement of VSNLs in various neurodegenerative disorders will be of interest in the future.
An emerging theme: VSNLs affecting membrane trafficking
In addition to the effect of NCS proteins on gene expression, which is currently receiving increasing attention, an emerging theme is their effect on the trafficking of ion channels and surface receptors. NCS proteins, such as KChIPs and NCS-1, have been shown to influence the surface expression of Ca 2+ and potassium channels Weiss et al. 2000) . KChIP1 influences the postendoplasmic reticulum trafficking of Kv4 potassium channels O'Callaghan et al. 2003b ). NCS-1 interacts with ARF1 to control trans-Golgi network (TGN)-plasma membrane trafficking of the Kv4 potassium channel (Zhao et al. 2001; Haynes et al. 2005) . In an approach to finding proteins that are linked to clathrin-mediated trafficking, VILIP-1 and VILIP-3 have been identified as interacting with clathrin-coated vesicles from rat brain ( Fig. 2 ; Blondeau et al. 2004) . Vesicles enriched in the clathrin heavy and light chain, the α, β, γ, μ−adaptin subunits of the AP-2 complex (which functions at the plasma membrane), and the AP-1 complex (which functions at the TGN) are also associated with VILIP-1 and VILIP-3 (Fig. 2) . Thus, VSNLs might be involved in clathrin-dependent membrane trafficking processes; this is in agreement with a proposed role of VILIP-1 as the regulator of post-Golgi membrane trafficking. VILIP-1 is able to increase the cellsurface expression of α4β2 nAChRs (Lin et al. 2002a (Lin et al. , 2002b but also influences the receptor recycling of transferrin and GC-B receptor in a clathrin-dependent manner (Brackmann et al. 2005) . Neurocalcin δ is able to interact with α-and β-clathrin and β-2-adaptin, important adapter proteins for receptor endocytosis . Similarly, hippocalcin binds the β-2-adaptin subunit of the AP2 adaptor complex, which together with GluR2 can co-immunoprecipitate in a Ca 2+ -sensitive manner. Infusion of a truncated mutant of hippocalcin that lacks the Ca 2+ -binding domains prevents synaptically evoked LTD, with no effect on long-term potentiation; this has led to a debate as to whether the AP2-hippocalcin complex acts as a Ca 2+ sensor that couples NMDAR-dependent activation to the regulated endocytosis of AMPARs during LTD (Palmer et al. 2005) . However, of note, the binding of GST-hippocalcin and GSTneurocalcin δ to α-adaptin or γ-adaptin from brain extracts could not be confirmed in a large-scale protein pull-down approach (Haynes et al. 2006 ). More recently, neurocalcin δ has been implicated in the trafficking and membrane delivery of glutamate receptors of the kainate type, which have been identified as key players in the modulation of neuronal network activity . Neurocalcin δ binds to the C-terminal domain of the GluR6b kainate receptor isoform and, thereby, might regulate kainate receptor trafficking and function during synapse formation and synaptic plasticity, similar to the effect of AMPAR and NMDAR regulation . Thus, VSNLs appear to interact with molecules connected to membrane trafficking and to affect the trafficking of multiple receptors; however, the mechanism of the VSNL effect on the transport machinery remains to be discovered.
Critical remarks: artifacts, pleiotropy, and in vivo functions
A variety of effects of VSNLs on signaling pathways have been identified, indicating that VSNLs similar to the prototypical calcium sensor calmodulin, have pleiotropic functions in the brain and peripheral organs. However, only a few signaling components from these pathways have been identified as interaction partners. The search for specific interaction partners for VSNLs have turned out to be difficult (Spilker et al. 2002b; Haynes et al. 2006) , and the signaling and physiological significance of the interactions that have been found often remain unclear (Haynes et al. 2006 ). An interaction partner has only been characterized for hippocalcin with respect to physiological function at the in vitro and in vivo level in knock-out animals (Mercer et al. 2000; Lindholm et al. 2002; Korhonen et al. 2005) . In other cases, interaction with components of signaling pathways, e.g., guanylyl cyclase, has been shown (Braunewell et al. 2001a (Braunewell et al. , 2001b Duda et al. 2001 Duda et al. , 2004 , although the precise interaction domains of VSNLs with these interaction partners have not as yet been mapped, and physiological functions remain unknown (Brackmann et al. 2005; Venkataraman et al. 2008; Duda and Sharma 2008) . The effect of VILIP-1 on adenylyl cyclase is most likely indirect, since no direct interactions have been found, and no influence has been detected in membrane cyclase assays (unpublished data). Some of the signaling effects might be dependent on indirect effects, e.g., by affecting cross-talk between signaling pathways, but effects on the trafficking of receptors and membrane-localized signaling compounds are also conceivable, particularly since this is one of the novel emerging signaling mechanisms of VSNLs. There is definitely a need for more and comparative yeast 2-hybrid and biochemical studies, even though the outcome might be limited and functional significance of identified interactions might be uncertain. In some cases, functional effects, e.g., on cAMP signaling, have been initially only described in overexpression studies . Nevertheless, in the case of cAMP signaling, the results have been consistently repeated by different research groups (Lin et al. 2002b; Mahloogi et al. 2003 ) and finally have also been supported by siRNA knock-down studies (Dai et al. 2006 ). In the future, the use of siRNA and other knock-out technologies will have to prove the correctness of many of the signaling functions identified to date. In terms of physiological functions, only a few knock-outs, e.g., hippocalcin -/-mutants, have been generated and partially analyzed, e.g., regarding neuroprotective function (Korhonen et al. 2005; Masuo et al. 2007 ) and functions in learning and memory processes . Notably, VSNLs have been implicated in a series of pathophysiological functions in diseases ranging from hypertension to diabetic nephropathy, amyotrophic lateral sclerosis, stroke, AD, and schizophrenia (Kamide et al. 2005; Kamiyama et al. 2007; Lederer et al. 2007; Laterza et al. 2006; Schnurra et al. 2001; Gierke et al. 2008) . The molecular and cellular mechanisms of some of these pathophysiological aspects have just started to be elucidated (Gierke et al. 2008) . Thus, future analysis of knock-out animals and the combination of these knock-outs should greatly help our understanding of the physiological and pathophysiological functions of this important family of Ca 2+ -sensor proteins. This area of research will largely benefit from concerted research in different laboratories in order to confirm data and the current working hypothesis of effects on signaling, gene expression, and membrane trafficking of these different but closely related members of VSNLs.
Concluding remarks
The VSNL subfamily of NCS proteins defines a novel set of Ca 2+ -dependent signaling cascades in nerve and cancer cells. The Ca 2+ -myristoyl switch mechanism of VSNLs can shuttle information from the cytoplasm to the cell membrane and vice versa enabling the different VSNLs to confer Ca 2+ -dependence to intracellular signaling pathways, such cyclic nucleotide and MAPK signaling. VSNLs might regulate membrane trafficking processes via different vesicular pathways from the endoplasmic reticulum and Golgi to the cell surface and the recycling pathway for receptors (Fig. 3) . Finally, VSNLs might regulate gene expression. Through these global mechanisms, VSNLs might contribute to processes of cell death, migration, differentiation, and neuronal plasticity under both physiological and pathological conditions. Fig. 3 The VSNL subfamily of NCS proteins may serve as Ca 2+ -dependent modulators of membrane receptor (R) trafficking. Following neurotransmitter activation and neuronal activity, VSNLs translocate in a Ca 2+ -dependent manner to intracellular and cell-surface membranes. VILIP-1 is a modulator of membrane-localized function and trafficking of natriuretic peptide receptors and nicotinic acetylcholine receptors (Lin et al. 2002a (Lin et al. , 2002b Brackmann et al. 2005; Gierke et al. 2008) . Like VILIP-1, neurocalcin δ and hippocalcin have been identified as modulators of guanylyl cyclase (olfactory and retinal guanylyl cyclase receptors; Mammen et al. 2004) . Moreover, VILIP-1 and neurocalcin δ have been implicated in the modulation of the trafficking of glutamate receptors of the kainate subtype . Hippocalcin acts as a Ca 2+ sensor for AMPA receptor endocytic trafficking (Palmer et al. 2005) . Thus, VSNLs might influence membrane trafficking of receptors at various check points, such as endo-or exocytosis or receptor recycling
